TY - JOUR T1 - The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada JF - medRxiv DO - 10.1101/19008409 SP - 19008409 AU - Arnaud Godin AU - Nadine Kronfli AU - Joseph Cox AU - Michel Alary AU - Mathieu Maheu-Giroux Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/10/21/19008409.abstract N2 - Background In Canada, hepatitis C virus (HCV) transmission primarily occurs among people who inject drugs (PWID) and people with experience in the prison system bare a disproportionate HCV burden. These overlapping groups of individuals have been identified as a priority populations for HCV micro-elimination in Canada, a country currently not on track to achieve its elimination targets. Considering the missed opportunities to intervene in provincial prisons, this study aims to estimate the population-level impact of prison-based interventions and post-release risk reduction strategies on HCV transmission among PWID in high HCV-burdened Canadian city, Montréal.Methods A dynamic HCV transmission model among PWID was developed and calibrated to community and prison bio-behavioural surveys in Montréal. The, the relative impact of prison-based testing and treatment or post-release linkage to care, alone or in combination with risk reduction strategies, was estimated from 2018 to 2030, and compared to counterfactual status quo scenario.Results Testing and linkage to care interventions implemented over 2018-30 could lead to the greatest declines in prevalence (23%; 95% Credible interval(CrI):17–31%), incidence (20%; 95%CrI: 10–28%), and prevent the most new chronic infections (8%; 95%CrI: 4–11%). Testing and treatment in prison could decrease prevalence, incidence, and fraction of prevented new chronic infections. Combining test and linkage to care with risk reduction measures could further its epidemiological impact, preventing 10% (95%CrI: 5–16%) of new chronic infections. When implemented concomitantly with community-based treatment scale-up, both prison-based interventions had synergistic effects, averting a higher fraction of new chronic infections.Conclusion Offering HCV testing and post-release linkage to care in provincial prisons, where incarcerations are frequent and sentences short, could change the course of the HCV epidemic in Montréal. Integration of post-release risk reduction measures and community-based treatment scale-up could also increase the impact of these interventions.Competing Interest StatementThis work was supported by the Canadian Network on Hepatitis C; and the Fond de recherche du Québec – Santé, as part AG’s master’s training funding. MM-G reports an investigator-sponsored research grant from Gilead Sciences Inc., grants from the Canadian Institutes of Health Research and the Canadian Foundation for AIDS Research, and contractual arrangements from both the World Health Organization and the Joint United Nations Programme on HIV/AIDS (UNAIDS), all outside of the submitted work. MM-G and NK’s research programs are funded by career awards from the Fonds de recherche du Québec – Santé. JC reports support for investigator-sponsored grants from Merck Canada, Gilead Sciences Canada and ViiV Healthcare. He has also received honorarium and travel support from Merck Canada, Gilead Sciences Canada and ViiV Healthcare. MA reports funding from the Canadian Institutes of Health Research and from the Bill & Melinda Gates Foundation, all outside of the submitted work. Funders were not involved in the conceptualisation and methodology of the project, data curation, formal analysis, or writing of the manuscript.Funding StatementThis work was supported by the Canadian Network on Hepatitis C; and the Fond de recherche du Québec – Santé, as part AG’s master’s training funding. Funders were not involved in the conceptualisation and methodology of the project, data curation, formal analysis, or writing of the manuscriptAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableOnline supplemental material is available with specification on model structure and methods for model calibration. Data used for calibration is publicly available from published reports and studies. ER -